Authors
Weiya Zhang, Michael Doherty, Nigel Arden, Bernard Bannwarth, Johannes Bijlsma, Klaus-Peter Gunther, Hans Jörg Hauselmann, Gabriel Herrero-Beaumont, Kelsey Jordan, Phaedon Kaklamanis, Burkhard Leeb, Michel Lequesne, Stefan Lohmander, Bernard Mazieres, Emilio Martin-Mola, Karel Pavelka, Adrian Pendleton, Leonardo Punzi, Berndt Swoboda, Ricardo Varatojo, Gust Verbruggen, Irena Zimmermann-Gorska, Maxime Dougados
Publication date
2005/5/1
Source
Annals of the rheumatic diseases
Volume
64
Issue
5
Pages
669-681
Publisher
BMJ Publishing Group Ltd
Description
Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).
Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 European countries. Each participant contributed up to 10 propositions describing key clinical aspects of hip OA management. Ten final recommendations were agreed using a Delphi consensus approach. Medline, Embase, CINAHL, Cochrane Library, and HTA reports were searched systematically to obtain research evidence for each proposition. Where possible, outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. Effect size, rate ratio, number needed to treat, and incremental cost effectiveness ratio were calculated. The quality of evidence was categorised according to the evidence hierarchy. The strength of …
Total citations
Scholar articles
W Zhang, M Doherty, N Arden, B Bannwarth, J Bijlsma… - Annals of the rheumatic diseases, 2005
W Zhang, M Doherty, N Arden, B Bannwarth, J Bijlsma… - Annals of the Rheumatic Diseases, 2005